Verve: Base Editing Gene Therapy Shows Promising Results in Cholesterol Reduction
Verve Therapeutics reported on Sunday that the first ten recipients of a one-time treatment utilizing base editing, a type of CRISPR, had lower levels of bad cholesterol.
These are early results, but they suggest that gene-editing…